PUBLISHER: KBV Research | PRODUCT CODE: 1431154
PUBLISHER: KBV Research | PRODUCT CODE: 1431154
North America Pancrelipase Market Size, Share & Trends Analysis Report By Age (Adults & Geriatrics, and Children), By Distribution Channel, By Application (Chronic Pancreatitis, Cystic Fibrosis, and Others), By Country and Growth Forecast, 2023 - 2030
The North America Pancrelipase Market would witness market growth of 3.8% CAGR during the forecast period (2023-2030).
Pancrelipase, a blend of lipase, protease, and amylase, mimics the natural digestive processes in the pancreas. It is prescribed primarily for patients with conditions such as cystic fibrosis, chronic pancreatitis, and pancreatic cancer, where the pancreas fails to produce adequate digestive enzymes. This enzyme therapy aids in breaking fats, proteins, and carbohydrates, facilitating nutrient absorption and maintaining overall digestive health.
An exocrine pancreatic insufficiency-related class of drugs is used to treat malabsorption and abdominal pain. It is utilized when the pancreas is unable to produce or release sufficient amounts of digestive enzymes into the small intestines to adequately digest the food (conditions like chronic pancreatitis, cystic fibrosis, cancer of the pancreas, post-pancreatectomy, post-gastrointestinal bypass surgery). This medicine is a combination of lipase, protease, and amylase. Purified porcine pancreatic lipase, amylase, and protease enzymes make this drug.
According to the Canadian Institute for Health Information, in 2023, total health expenditures in Canada are projected to increase by 2.8%, compared to a modest 1.5% increase in 2022. By 2023, Canadian health expenditures are projected to total $344 billion, or $8,740 per Canadian. Additionally, by 2023, health-related expenses are projected to account for 12.1% of Canada's gross domestic product (GDP). Higher healthcare spending allows for investments in advanced healthcare services, including diagnostic facilities and specialized clinics. Improved access to healthcare services facilitates early diagnosis of pancreatic disorders, leading to increased demand for therapy. Thus, the above aspects will expand the market growth across the region in the upcoming years.
The US market dominated the North America Pancrelipase Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $899.3 Million by 2030. The Canada market is experiencing a CAGR of 6.2% during (2023 - 2030). Additionally, The Mexico market would exhibit a CAGR of 5.3% during (2023 - 2030).
Based on Age, the market is segmented into Adults & Geriatrics, and Children. Based on Distribution Channel, the market is segmented into Drug Store & Retail Pharmacies, Hospital Pharmacies, and Online Pharmacies. Based on Application, the market is segmented into Chronic Pancreatitis, Cystic Fibrosis, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
List of Key Companies Profiled
- Organon & Co.
- Digestive Care, Inc.
- AbbVie, Inc.
- Vivus LLC
- Laboratorio Opoterapico Argentino S.A.
- Nestle S.A
- Scientific Protein Laboratories, LLC (Hepalink)
North America Pancrelipase Market Report Segmentation
By Age
- Adults & Geriatrics
- Children
By Distribution Channel
- Drug Store & Retail Pharmacies
- Hospital Pharmacies
- Online Pharmacies
By Application
- Chronic Pancreatitis
- Cystic Fibrosis
- Others
By Country
- US
- Canada
- Mexico
- Rest of North America
Table of Contents
Chapter 1. Market Scope & Methodology
- 1.1 Market Definition
- 1.2 Objectives
- 1.3 Market Scope
- 1.4 Segmentation
- 1.4.1 North America Pancrelipase Market, by Age
- 1.4.2 North America Pancrelipase Market, by Distribution Channel
- 1.4.3 North America Pancrelipase Market, by Application
- 1.4.4 North America Pancrelipase Market, by Country
- 1.5 Methodology for the research
Chapter 2. Market at a Glance
- 2.1 Key Highlights
Chapter 3. Market Overview
- 3.1 Introduction
- 3.1.1 Overview
- 3.1.1.1 Market Composition and Scenario
- 3.1.1 Overview
- 3.2 Key Factors Impacting the Market
- 3.2.1 Market Drivers
- 3.2.2 Market Restraints
- 3.2.3 Market Opportunities
- 3.2.4 Market Challenges
- 3.3 Porter Five Forces Analysis
Chapter 4. North America Pancrelipase Market by Age
- 4.1 North America Adults & Geriatrics Market by Country
- 4.2 North America Children Market by Country
Chapter 5. North America Pancrelipase Market by Distribution Channel
- 5.1 North America Drug Store & Retail Pharmacies Market by Country
- 5.2 North America Hospital Pharmacies Market by Country
- 5.3 North America Online Pharmacies Market by Country
Chapter 6. North America Pancrelipase Market by Application
- 6.1 North America Chronic Pancreatitis Market by Country
- 6.2 North America Cystic Fibrosis Market by Country
- 6.3 North America Others Market by Country
Chapter 7. North America Pancrelipase Market by Country
- 7.1 US Pancrelipase Market
- 7.1.1 US Pancrelipase Market by Age
- 7.1.2 US Pancrelipase Market by Distribution Channel
- 7.1.3 US Pancrelipase Market by Application
- 7.2 Canada Pancrelipase Market
- 7.2.1 Canada Pancrelipase Market by Age
- 7.2.2 Canada Pancrelipase Market by Distribution Channel
- 7.2.3 Canada Pancrelipase Market by Application
- 7.3 Mexico Pancrelipase Market
- 7.3.1 Mexico Pancrelipase Market by Age
- 7.3.2 Mexico Pancrelipase Market by Distribution Channel
- 7.3.3 Mexico Pancrelipase Market by Application
- 7.4 Rest of North America Pancrelipase Market
- 7.4.1 Rest of North America Pancrelipase Market by Age
- 7.4.2 Rest of North America Pancrelipase Market by Distribution Channel
- 7.4.3 Rest of North America Pancrelipase Market by Application
Chapter 8. Company Profiles
- 8.1 Organon & Co.
- 8.1.1 Company Overview
- 8.1.2 Financial Analysis
- 8.1.3 Regional Analysis
- 8.1.4 Research & Development Expenses
- 8.2 Digestive Care, Inc.
- 8.2.1 Company Overview
- 8.3 Laboratorio Opoterapico Argentino S.A.
- 8.3.1 Company Overview
- 8.4 Scientific Protein Laboratories, LLC (Hepalink)
- 8.4.1 Company Overview
- 8.5 AbbVie, Inc.
- 8.5.1 Company Overview
- 8.5.2 Financial Analysis
- 8.5.3 Regional Analysis
- 8.5.4 Research & Development Expense
- 8.5.5 SWOT Analysis
- 8.6 Vivus LLC
- 8.6.1 Company Overview
- 8.7 Nestle S.A
- 8.7.1 Company Overview
- 8.7.2 Financial Analysis
- 8.7.3 Segmental and Regional Analysis
- 8.7.4 Research & Development Expenses
- 8.7.5 SWOT Analysis
LIST OF TABLES
- TABLE 1 North America Pancrelipase Market, 2019 - 2022, USD Million
- TABLE 2 North America Pancrelipase Market, 2023 - 2030, USD Million
- TABLE 3 North America Pancrelipase Market by Age, 2019 - 2022, USD Million
- TABLE 4 North America Pancrelipase Market by Age, 2023 - 2030, USD Million
- TABLE 5 North America Adults & Geriatrics Market by Country, 2019 - 2022, USD Million
- TABLE 6 North America Adults & Geriatrics Market by Country, 2023 - 2030, USD Million
- TABLE 7 North America Children Market by Country, 2019 - 2022, USD Million
- TABLE 8 North America Children Market by Country, 2023 - 2030, USD Million
- TABLE 9 North America Pancrelipase Market by Distribution Channel, 2019 - 2022, USD Million
- TABLE 10 North America Pancrelipase Market by Distribution Channel, 2023 - 2030, USD Million
- TABLE 11 North America Drug Store & Retail Pharmacies Market by Country, 2019 - 2022, USD Million
- TABLE 12 North America Drug Store & Retail Pharmacies Market by Country, 2023 - 2030, USD Million
- TABLE 13 North America Hospital Pharmacies Market by Country, 2019 - 2022, USD Million
- TABLE 14 North America Hospital Pharmacies Market by Country, 2023 - 2030, USD Million
- TABLE 15 North America Online Pharmacies Market by Country, 2019 - 2022, USD Million
- TABLE 16 North America Online Pharmacies Market by Country, 2023 - 2030, USD Million
- TABLE 17 North America Pancrelipase Market by Application, 2019 - 2022, USD Million
- TABLE 18 North America Pancrelipase Market by Application, 2023 - 2030, USD Million
- TABLE 19 North America Chronic Pancreatitis Market by Country, 2019 - 2022, USD Million
- TABLE 20 North America Chronic Pancreatitis Market by Country, 2023 - 2030, USD Million
- TABLE 21 North America Cystic Fibrosis Market by Country, 2019 - 2022, USD Million
- TABLE 22 North America Cystic Fibrosis Market by Country, 2023 - 2030, USD Million
- TABLE 23 North America Others Market by Country, 2019 - 2022, USD Million
- TABLE 24 North America Others Market by Country, 2023 - 2030, USD Million
- TABLE 25 North America Pancrelipase Market by Country, 2019 - 2022, USD Million
- TABLE 26 North America Pancrelipase Market by Country, 2023 - 2030, USD Million
- TABLE 27 US Pancrelipase Market, 2019 - 2022, USD Million
- TABLE 28 US Pancrelipase Market, 2023 - 2030, USD Million
- TABLE 29 US Pancrelipase Market by Age, 2019 - 2022, USD Million
- TABLE 30 US Pancrelipase Market by Age, 2023 - 2030, USD Million
- TABLE 31 US Pancrelipase Market by Distribution Channel, 2019 - 2022, USD Million
- TABLE 32 US Pancrelipase Market by Distribution Channel, 2023 - 2030, USD Million
- TABLE 33 US Pancrelipase Market by Application, 2019 - 2022, USD Million
- TABLE 34 US Pancrelipase Market by Application, 2023 - 2030, USD Million
- TABLE 35 Canada Pancrelipase Market, 2019 - 2022, USD Million
- TABLE 36 Canada Pancrelipase Market, 2023 - 2030, USD Million
- TABLE 37 Canada Pancrelipase Market by Age, 2019 - 2022, USD Million
- TABLE 38 Canada Pancrelipase Market by Age, 2023 - 2030, USD Million
- TABLE 39 Canada Pancrelipase Market by Distribution Channel, 2019 - 2022, USD Million
- TABLE 40 Canada Pancrelipase Market by Distribution Channel, 2023 - 2030, USD Million
- TABLE 41 Canada Pancrelipase Market by Application, 2019 - 2022, USD Million
- TABLE 42 Canada Pancrelipase Market by Application, 2023 - 2030, USD Million
- TABLE 43 Mexico Pancrelipase Market, 2019 - 2022, USD Million
- TABLE 44 Mexico Pancrelipase Market, 2023 - 2030, USD Million
- TABLE 45 Mexico Pancrelipase Market by Age, 2019 - 2022, USD Million
- TABLE 46 Mexico Pancrelipase Market by Age, 2023 - 2030, USD Million
- TABLE 47 Mexico Pancrelipase Market by Distribution Channel, 2019 - 2022, USD Million
- TABLE 48 Mexico Pancrelipase Market by Distribution Channel, 2023 - 2030, USD Million
- TABLE 49 Mexico Pancrelipase Market by Application, 2019 - 2022, USD Million
- TABLE 50 Mexico Pancrelipase Market by Application, 2023 - 2030, USD Million
- TABLE 51 Rest of North America Pancrelipase Market, 2019 - 2022, USD Million
- TABLE 52 Rest of North America Pancrelipase Market, 2023 - 2030, USD Million
- TABLE 53 Rest of North America Pancrelipase Market by Age, 2019 - 2022, USD Million
- TABLE 54 Rest of North America Pancrelipase Market by Age, 2023 - 2030, USD Million
- TABLE 55 Rest of North America Pancrelipase Market by Distribution Channel, 2019 - 2022, USD Million
- TABLE 56 Rest of North America Pancrelipase Market by Distribution Channel, 2023 - 2030, USD Million
- TABLE 57 Rest of North America Pancrelipase Market by Application, 2019 - 2022, USD Million
- TABLE 58 Rest of North America Pancrelipase Market by Application, 2023 - 2030, USD Million
- TABLE 59 Key Information - Organon & co.
- TABLE 60 Key Information - Digestive Care, Inc.
- TABLE 61 Key Information - Laboratorio Opoterapico Argentino S.A.
- TABLE 62 Key Information - Scientific Protein Laboratories, LLC
- TABLE 63 Key information - AbbVie, Inc.
- TABLE 64 Key Information - Vivus LLC
- TABLE 65 Key Information - Nestle S.A
